Celltrion Pharm Incorporated operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Celltrion Pharm Incorporated with three other
companies in this sector in South Korea:
Nutri Biotech Co Ltd
sales of 77.52 billion Korean Won [US$65.97 million]
Dongsung Pharmaceutical Company Limited
(74.66 billion Korean Won [US$63.54 million]
of which 86%
was Pharmaceutical Segment), and
JW Shinyak Corp
(76.95 billion Korean Won [US$65.48 million]
Celltrion Pharm Incorporated reported sales of 74.73 billion Korean Won (US$63.60 million)
December of 2015.
increase of 12.0%
versus 2014, when the company's sales were 66.74 billion Korean Won.
Sales at Celltrion Pharm Incorporated have increased during each of the previous five years
(and since 2010, sales have increased a total of 86%).